NCT02934100

Brief Summary

This study evaluates the effectiveness of physiotherapy and kinesiotherapy in patients with calcaneal spurs. the aim of the study is to compare the efficacy of calcaneal spurs treatment provided with extracorporeal shock wave therapy, ultrasound therapy, electric field diathermy associated with kinesiotherapy and sham laser in combination with kinesiotherapy. In each group kinesiotherapy treatment is the same and consists of an eight-minute massage of posterior lower leg muscles and plantar aponeurosis stretching.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 11, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 14, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2017

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2018

Completed
Last Updated

October 14, 2016

Status Verified

October 1, 2016

Enrollment Period

1 year

First QC Date

October 11, 2016

Last Update Submit

October 12, 2016

Conditions

Keywords

Calcaneal spurHeel spurESWTExtracorporeal shock wave therapyultrasound therapyelectric field diathermyskanlab 25 bodywavesham laser therapy

Outcome Measures

Primary Outcomes (3)

  • The American Orthopedic Foot and Ankle Society Score (AOFAS) - Change

    The American Orthopedic Foot and Ankle Society Score (AOFAS) is one of most widely used clinician-reporting tools for foot and ankle conditions. Developed in 1994, it is a clinician-based score that measures outcomes for four different anatomic regions of the foot: The ankle-hindfoot, midfoot, metatarsophalangeal (MTP)-interphalangeal (IP) for the hallux, and MTP-IP for the lesser toes. The four anatomic regions of the AOFAS are all represented by a different version of the survey with each tool designed to be used independently. The questionnaire consists of nine items that are distributed over three categories: Pain (40 points), function (50 points) and alignment (10 points). These are all scored together for a total of 100 points.

    Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.

  • The SF-36v2 Health Survey (SF-36v2) - Change

    The SF-36v2 Health Survey is a multipurpose, short-form health survey with 36 questions that yields an eight-scale profile of functional health and well-being, as well as two psychometrically based physical and mental health summary measures and a preference-based health utility index. Like its predecessor, the SF-36 Health Survey , the SF-36v2 is a generic measure of health status, as opposed to one that targets a specific age, disease, or treatment group. It has proven useful for conducting surveys of general and specific populations, comparing the relative burden of diseases, and differentiating the health benefits produced by a wide range of treatments.

    Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.

  • The Laitinen Pain Indicator Questionnaire

    The Laitinen Pain Indicator Questionnaire is subjective and point tool which is used to assess the level of pain. Patients have to evaluate four indicators: pain intensity, the frequency of pain, the frequency of use of analgesics and physical activity limitations. Each indicator score is assigned from 0 to 4, with 0 being no problem, and four being a maximum problem.

    Change from before the treatment and right after the treatment. Also change from after the treatment at 2 months.

Secondary Outcomes (3)

  • Two weights test

    Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.

  • Heel standing test

    Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.

  • The Visual Analogue Scale

    Patients will be screened using this scale three times: before treatment, immediately after its completion and two months after the end of therapy.

Study Arms (4)

Group 1 - ESWT Treatment

ACTIVE COMPARATOR

Patients treated with Extracorporeal Shock Wave Therapy once a week for 10 weeks

Device: Shock Master 300

Group 2 - Body Wave

ACTIVE COMPARATOR

Patients treated with electric field diathermy three times a week for 5 weeks

Device: Skanlab 25 BODYWAVE

Group 3 - Ultrasound

ACTIVE COMPARATOR

Patients treated with ultrasound therapy three times a week for 5 weeks

Device: EVO US13 CosmoGamma

Group 4 - Control group

SHAM COMPARATOR

Patients treated with sham laser therapy three times a week for 5 weeks

Device: Sham LASER CTL1106MX

Interventions

Extracorporeal Shock Wave Therapy In all treatments (from 1 to 10) applied number of pulses is 4500 and the frequency is based on the patients feelings (from 8 to 12 Hz). Variable is the pressure: Treatment 1 - 2,5 Bar; Treatment 2 - 2,6 Bar; Treatment 3 - 2,7 Bar; Treatment 4 - 2,8 Bar; Treatment 5 - 3,0 Bar; Treatment 6 - 3,2 Bar; Treatment 7 - 3,4 Bar; Treatment 8 - 3,6 Bar; Treatment 9 - 3,8 Bar; Treatment 10 - 4,0 Bar. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

Also known as: produced by GYMNA
Group 1 - ESWT Treatment

Electric field diathermy therapy - Capacitive energy transfer system (CETS) Time of each treatment (from 1 to 15) is eight minutes. Variable is the energy: Treatment 1 - 3; Treatment 2 - 3; Treatment 3 - 4; Treatment 4 - 4; Treatment 5 - 5; Treatment 6 - 5; Treatment 7 - 6; Treatment 8 - 6; Treatment 9 - 7; Treatment 10 - 7; Treatment 11 - 7; Treatment 12 - 7; Treatment 13 - 7; Treatment 14 - 7; Treatment 15 - 7. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

Also known as: produced by SKANLAB AS
Group 2 - Body Wave

Ultrasound therapy Doses applied as following: Each treatment (from 1 to 15) is pulsed ultrasound (1MHz, pulsed 1:4). Variable is the time and intensity: Treatment 1 - 4 minutes, 0,4 W/cm2; Treatment 2 - 5 minutes, 0,4 W/cm2; Treatment 3 - 5 minutes, 0,5 W/cm2; Treatment 4 - 6 minutes, 0,5 W/cm2; Treatment 5 - 6 minutes, 0,6 W/cm2; Treatment 6 - 6 minutes, 0,6 W/cm2; Treatment 7 - 6 minutes, 0,6 W/cm2; Treatment 8 - 6 minutes, 0,7 W/cm2; Treatment 9 - 7 minutes, 0,7 W/cm2; Treatment 10 - 7 minutes, 0,7 W/cm2; Treatment 11 - 7 minutes, 0,8 W/cm2; Treatment 12 - 8 minutes, 0,8 W/cm2; Treatment 13 - 8 minutes, 0,8 W/cm2; Treatment 14 - 8 minutes, 0,8 W/cm2; Treatment 15 - 8 minutes, 0,8 W/cm2. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

Also known as: produced by EMILDUE
Group 3 - Ultrasound

Sham laser therapy Time of each treatment (from 1 to 15) is four to five minutes. Developed is 10 points, each point takes 15 seconds. Device is unplugged and it does not emit any radiation.The patient does not know that the procedure is not really executed. Each patient will also receive kinesiotherapy treatment that will consist of: * eight-minute massage of posterior lower leg muscles * plantar aponeurosis stretching

Also known as: produced by CTL
Group 4 - Control group

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • heel spur (calcaneal spur) diagnosed by a doctor based on X-ray examination, diagnostic ultrasonography or MR
  • signed informed consent
  • heel pain for at least one month

You may not qualify if:

  • pregnancy
  • generalized acute infection (fever, cough, runny nose)
  • local infection in the treated leg (wound, swelling)
  • cancer
  • injections of corticosteroids in the last six weeks
  • pacemaker
  • acute inflammation of the joints of the lower limbs
  • inflammation of the veins
  • Fresh fractures, post-traumatic
  • osteoporosis
  • Reynaud's disease
  • Burger disease
  • atherosclerosis
  • after surgery condition before removing stitches
  • High blood pressure
  • +14 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Non-public health care facility "NZOZ Komed"

Lodz, Łódź Voivodeship, 90-009, Poland

RECRUITING

Related Links

MeSH Terms

Conditions

Heel Spur

Condition Hierarchy (Ancestors)

ExostosesHyperostosisBone DiseasesMusculoskeletal DiseasesFoot Diseases

Study Officials

  • Natalia Kociuga, master

    Medical University of Lodz, Poland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Natalia Kociuga, master

CONTACT

Marta Woldańska-Okońska, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master of Physical Therapy

Study Record Dates

First Submitted

October 11, 2016

First Posted

October 14, 2016

Study Start

August 1, 2016

Primary Completion

August 1, 2017

Study Completion

June 1, 2018

Last Updated

October 14, 2016

Record last verified: 2016-10

Locations